FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of biologically active compounds exhibiting antiviral effect against the strain of influenza virus A/Puerto Rico/8/34 (H1N1) and constituting dimethyl 7-methyl-2-(pyrrolidine-1-yl)-4-phenylpyrrolo[2,1-ƒ][1,2,4]triazine-5,6-dicarboxylate by the formula (7)
and dimethyl 7-methyl-2-(4-R1-phenyl)-4-(4-R2-phenyl)pyrrolo[2,1-ƒ][1,2,4]triazine-5,6-dicarboxylates by the formula (8) , wherein R1 is Me and R2 is Me; or R1 is Cl and R2 is Me; or R1 is H and R2 is Cl.
EFFECT: creation of new chemical compounds of the azoloazine series — dimethyl 7-methyl-2-(pyrrolidine-1-yl)-4-phenylpyrrolo[2,1-ƒ][1,2,4]triazine-5,6-dicarboxylate by the formula (7) and dimethyl 7-methyl-2-(4-R1-phenyl)-4-(4-R2-phenyl)pyrrolo[2,1-ƒ][1,2,4]triazine-5,6-dicarboxylates by the formula (8), exhibiting a significant antiviral effect against the strain of influenza virus A/Puerto Rico/8/34 (H1N1).
2 cl, 6 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
DIMETHYL 7-METHYL-2-n-TOLYL-4-PHENYLPYRROLO[2,1-f] [2,1,4]TRIAZINE-5,6-DICARBOXYLATE WITH ANTICOAGULANT EFFECT | 2022 |
|
RU2790375C1 |
6-(2'-AMINO-2'-CARBOXYETHYLTHIO)-2-METHYLTHIO-4-PIVALOYLOXY-METHYL-1,2,4-TRIAZOLO[5,1-c] 1,2,4-TRIAZIN-7(4H)-ONE | 2011 |
|
RU2455304C1 |
4-(4'-HYDROXYBUTYL)-6-PHENYL-1,2,4-TRIAZOLO[5,1-c][1,2,4]TRIAZIN-7-ON | 2007 |
|
RU2345080C2 |
2-R-4-(ALLYLOXYMETHYL)-6-NITRO-1,2,4-TRIASOLO[5,1-C]-1,2,4-TRIAZIN-7(4H)-ONS AND 2-R-4-(PROPARGYLOXYMETHYL)-6-NITRO-1,2,4-TRIASOLO[5,1-C]-1,2,4-TRIAZIN7(4H)-ONS, POSSESSING ANTI-VIRAL ACTIVITY | 2006 |
|
RU2340614C2 |
4-((Z)-4'-HYDROXYBUTENE-2'-YL)-2-R-6-FURYL-1,2,4-TRIAZOLO[5,1-c][1,2,4]TRIAZINE-7-ONS | 2008 |
|
RU2376307C1 |
DERIVATIVES OF 1,2,4-TRIAZINE-4-AMINE | 2011 |
|
RU2625791C2 |
[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZINES EXHIBITING ACTIVITY AGAINST INFLUENZA VIRUS, AND METHOD FOR PRODUCTION THEREOF | 2022 |
|
RU2824814C2 |
SODIUM SALT OF 2-METHYL-6-FLUORO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4H)-ONE DIHYDRATE, HAVING ANTIVIRAL ACTIVITY | 2009 |
|
RU2493158C2 |
SUBSTITUTED 3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2720305C1 |
CONJUGATES OF 2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4I')-ONE WITH GLUTADIONE AND OTHER PEPTIDES, POSSESSING ANTIVIRAL ACTIVITY | 2012 |
|
RU2516936C2 |
Authors
Dates
2023-02-17—Published
2021-12-28—Filed